Publications
Detailed Information
VITREOUS HEMORRHAGE AFTER THE 25-GAUGE TRANSCONJUNCTIVAL SUTURELESS VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Byung Joo | - |
dc.contributor.author | Yu, Hyeong Gon | - |
dc.date.accessioned | 2012-06-29T00:34:56Z | - |
dc.date.available | 2012-06-29T00:34:56Z | - |
dc.date.issued | 2010-12 | - |
dc.identifier.citation | RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES; Vol.30 10; 1671-1677 | ko_KR |
dc.identifier.issn | 0275-004X | - |
dc.identifier.uri | https://hdl.handle.net/10371/77845 | - |
dc.description.abstract | Purpose: To address the incidence, clinical course, and risk factors for postoperative vitreous hemorrhage (PVH) after a 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy. Methods: A consecutive series of eyes underwent 25-gauge transconjunctival sutureless vitrectomies for proliferative diabetic retinopathy. The best-corrected visual acuities and intraocular pressures were measured, and the complications were prospectively evaluated 1 day, 1 week, 1 month, and 3 months postoperatively, then as needed. Results: The mean postoperative follow-up was 11.0 +/- 6.3 months (range, 6-28 months). Of 93 eyes, 42 had PVH on Day 1 (immediate PVH) but the presence and degree of PVH did not affect visual recovery and only 4 eyes did not clear for 1 month (persistent PVH). Recurrent PVH occurred in 11 eyes. Eight eyes had hypotony on Day 1, and patients who experienced postoperative hypotony had an 11.20-fold increased risk of immediate PVH > Grade 2. In the cases that needed intravitreal tamponade, the risk of recurrent PVH was 3.03-fold higher. Conclusion: After 25-gauge transconjunctival sutureless vitrectomies for proliferative diabetic retinopathy, postoperative hypotony and the need for tamponade increased the rates of immediate and recurrent PVH, respectively. Immediate PVH occurred in 45.2% of the patients but did not affect early visual recovery. A 25-gauge transconjunctival sutureless vitrectomy resulted in a favorable incidence of recurrent PVH (11.8%) during the first 6 months. RETINA 30:1671-1677, 2010 | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | ko_KR |
dc.subject | 25-gauge transconjunctival sutureless vitrectomy | ko_KR |
dc.subject | risk factor | ko_KR |
dc.subject | proliferative diabetic retinopathy | ko_KR |
dc.subject | diabetic vitrectomy | ko_KR |
dc.subject | postoperative vitreous hemorrhage | ko_KR |
dc.title | VITREOUS HEMORRHAGE AFTER THE 25-GAUGE TRANSCONJUNCTIVAL SUTURELESS VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 이병주 | - |
dc.contributor.AlternativeAuthor | 유형곤 | - |
dc.identifier.doi | 10.1097/IAE.0b013e3181dcfb79 | - |
dc.citation.journaltitle | RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | - |
dc.description.citedreference | Romano MR, 2009, EYE, V23, P1698, DOI 10.1038/eye.2008.354 | - |
dc.description.citedreference | Altan T, 2008, RETINA-J RET VIT DIS, V28, P1201 | - |
dc.description.citedreference | Faghihi H, 2008, RETINA-J RET VIT DIS, V28, P1241 | - |
dc.description.citedreference | Hsu J, 2008, RETINA-J RET VIT DIS, V28, P937 | - |
dc.description.citedreference | Acar N, 2008, RETINA-J RET VIT DIS, V28, P545 | - |
dc.description.citedreference | Yorston D, 2008, BRIT J OPHTHALMOL, V92, P365, DOI 10.1136/bjo.2007.124495 | - |
dc.description.citedreference | Yang CM, 2007, OPHTHALMOLOGY, V114, P710, DOI 10.1016/j.ophtha.2006.07.047 | - |
dc.description.citedreference | Schiff WM, 2007, OPHTHALMOLOGY, V114, P544, DOI 10.1016/j.ophtha.2006.08.017 | - |
dc.description.citedreference | Kadonosono K, 2006, AM J OPHTHALMOL, V142, P513 | - |
dc.description.citedreference | Yeh PT, 2005, OPHTHALMOLOGY, V112, P2095, DOI 10.1016/j.ophtha.2005.07.010 | - |
dc.description.citedreference | Soto-Pedre E, 2005, OPHTHAL EPIDEMIOL, V12, P335 | - |
dc.description.citedreference | Shimada H, 2005, JPN J OPHTHALMOL, V49, P397, DOI 10.1007/s10384-004-0214-4 | - |
dc.description.citedreference | Mason JO, 2005, AM J OPHTHALMOL, V140, P231, DOI 10.1016/j.ajo.2005.02.052 | - |
dc.description.citedreference | Cusick M, 2005, AM J OPHTHALMOL, V139, P1042, DOI 10.1016/j.ajo.2005.01.008 | - |
dc.description.citedreference | Hershberger VS, 2004, OPHTHALMOLOGY, V111, P1215, DOI 10.1016/j.ophtha.2003.08.043 | - |
dc.description.citedreference | Fujii GY, 2002, OPHTHALMOLOGY, V109, P1814 | - |
dc.description.citedreference | Bhende M, 2000, OPHTHALMOLOGY, V107, P1729 | - |
dc.description.citedreference | BROWN GC, 1992, ARCH OPHTHALMOL-CHIC, V110, P506 | - |
dc.description.citedreference | KRIEGER AE, 1991, T AM OPHTHAL SOC, V89, P549 | - |
dc.description.citedreference | TOLENTINO FI, 1989, OPHTHALMOLOGY, V96, P1495 | - |
dc.description.citedreference | BLANKENSHIP GW, 1986, OPHTHALMOLOGY, V93, P39 | - |
dc.description.citedreference | NOVAK MA, 1984, OPHTHALMOLOGY, V91, P1485 | - |
dc.description.tc | 0 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.